Access to Medicines Is Not the Business of the Pharma Industry

Journal of the International Association of Physicians in AIDS Care
doi 10.1177/154510970200100102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Access to Medicines—business as Usual?

The Lancet Global Health
Medicine
2019English

Open Innovation and Licensing in the Pharma Industry

Folia Pharmacologica Japonica
Pharmacology
2013English

PHP111 Global Evidence Generation - Challenges for the Pharma Industry

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Pcp10 - Patient Access to New Medicines; The Changing Landscape

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

TheSocialMedwork: Providing Access to Overseas Medicines

Prescriber
Pharmacology
2019English

When Is Open Access Not Open Access?

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2007English

Reforming Canada's Access to Medicines Regime

CMAJ
Medicine
2007English

How the MDGs Gave Up on Measuring Access to Medicines

The Lancet Global Health
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy